Form S-3

Sangamo Therapeutics Announces Pricing of $24.0 Million Registered Direct Offering

Retrieved on: 
Friday, March 22, 2024
Health, Neurology, Genetics, Clinical Trials, Pharmaceutical, Biotechnology, AAV, Sangamo Therapeutics, Form, Telephone, Sale, Attention, Security (finance), Prospectus, Form S-3, Capital market, Cantor, Broadridge Financial Solutions, Therapy, Barclays

The combined offering price of each share of common stock and accompanying warrant is $0.84, priced at-the-market under Nasdaq rules.

Key Points: 
  • The combined offering price of each share of common stock and accompanying warrant is $0.84, priced at-the-market under Nasdaq rules.
  • The combined offering price of each pre-funded warrant and accompanying warrant is $0.83.
  • The gross proceeds to Sangamo from the offering, before deducting the placement agents’ fees and other offering expenses, are expected to be approximately $24.0 million.
  • The offering is expected to close on or about March 26, 2024, subject to customary closing conditions.

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Retrieved on: 
Thursday, March 21, 2024
Food, Beverage, Retail, Common stock, Form, Sale, BROS, Security (finance), Prospectus, Morgan Stanley, Form S-3, File, TSG Consumer Partners, 2nd Floor

Dutch Bros Inc. (NYSE: BROS; “Dutch Bros” or the “Company”) today announced commencement of a registered underwritten public offering of its Class A common stock, par value $0.00001 per share (the “Common Stock”), by certain selling stockholders associated with TSG Consumer Partners, L.P. (the “Selling Stockholders”).

Key Points: 
  • Dutch Bros Inc. (NYSE: BROS; “Dutch Bros” or the “Company”) today announced commencement of a registered underwritten public offering of its Class A common stock, par value $0.00001 per share (the “Common Stock”), by certain selling stockholders associated with TSG Consumer Partners, L.P. (the “Selling Stockholders”).
  • The Selling Stockholders also intend to grant the underwriter a 30-day option to purchase up to an additional 1,200,000 shares of Common Stock.
  • Dutch Bros is not offering any shares of Common Stock in this offering and will not receive any proceeds from the sale of shares of Common Stock by the Selling Stockholders but will bear a portion of the costs associated with the sale of such shares, other than any underwriting discounts and commissions.
  • A shelf registration statement on Form S-3 relating to Dutch Bros’ securities, including the Common Stock, has been filed with the SEC and became effective upon such filing.

Dutch Bros Inc. Announces Pricing of Secondary Public Offering of Class A Common Stock

Retrieved on: 
Thursday, March 21, 2024
Retail, Professional Services, Food, Beverage, Finance, Common stock, Form, Sale, BROS, Prospectus, Morgan Stanley, Form S-3, File, TSG Consumer Partners, 2nd Floor, Security (finance)

Dutch Bros Inc. (NYSE: BROS; “Dutch Bros” or the “Company”) today announced pricing of the previously announced registered underwritten public offering by certain selling stockholders associated with TSG Consumer Partners, L.P. (the “Selling Stockholders”) of 8,000,000 shares of Dutch Bros’ Class A common stock, par value $0.00001 per share (the “Common Stock”) at a public offering price of $34.00 per share.

Key Points: 
  • Dutch Bros Inc. (NYSE: BROS; “Dutch Bros” or the “Company”) today announced pricing of the previously announced registered underwritten public offering by certain selling stockholders associated with TSG Consumer Partners, L.P. (the “Selling Stockholders”) of 8,000,000 shares of Dutch Bros’ Class A common stock, par value $0.00001 per share (the “Common Stock”) at a public offering price of $34.00 per share.
  • The Selling Stockholders granted the underwriters a 30-day option to purchase up to an additional 1,200,000 shares of Common Stock.
  • Dutch Bros is not offering any shares of Common Stock in this offering and will not receive any proceeds from the sale of shares of Common Stock by the Selling Stockholders but will bear a portion of the costs associated with the sale of such shares, other than any underwriting discounts and commissions.
  • A shelf registration statement on Form S-3 relating to Dutch Bros’ securities, including the Common Stock, has been filed with the SEC and became effective upon such filing.

Geron Corporation Announces Pricing of $150 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

Retrieved on: 
Tuesday, March 19, 2024
Science, Biotechnology, Research, Pharmaceutical, Oncology, Health, Hospitals, Clinical Trials, Montgomery Street, Form, Telephone, Corporation, Sale, Attention, Syndrome, Security (finance), Lexington Avenue, Suite, Form S-3, Prospectus, OrbiMed, Geron Corporation

Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced the pricing of an underwritten offering consisting of 41,999,998 shares of its common stock at a price of $3.00 per share and pre-funded warrants to purchase 8,002,668 shares of its common stock.

Key Points: 
  • Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced the pricing of an underwritten offering consisting of 41,999,998 shares of its common stock at a price of $3.00 per share and pre-funded warrants to purchase 8,002,668 shares of its common stock.
  • All of the securities in the offering are to be sold by Geron.
  • The offering is expected to close on or about March 21, 2024, subject to the satisfaction of customary closing conditions.
  • The gross proceeds to Geron from this underwritten offering, before deducting the underwriting discount and other estimated offering expenses, are expected to be approximately $150.0 million.

GE HealthCare Technologies Inc. Prices Upsized Secondary Offering of 14,000,000 Shares

Retrieved on: 
Wednesday, March 13, 2024
Professional Services, Health, Data Analytics, Hospitals, Health Technology, Other Health, Pharmaceutical, Offering, Communication, General Electric Company, Form, EDGAR, Sale, Attention, Prospectus, Morgan Stanley, Form S-3, GE HealthCare, Varick Street, 2nd Floor, Security (finance)

GE HealthCare Technologies Inc. (Nasdaq: GEHC) (the “Company” or “GE HealthCare”) announced today the pricing of the previously announced secondary underwritten public offering (the “Offering”) of 14,000,000 shares of its common stock (the “GEHC Shares”).

Key Points: 
  • GE HealthCare Technologies Inc. (Nasdaq: GEHC) (the “Company” or “GE HealthCare”) announced today the pricing of the previously announced secondary underwritten public offering (the “Offering”) of 14,000,000 shares of its common stock (the “GEHC Shares”).
  • The Offering was upsized from the previously announced offering size of 13,000,000 GEHC Shares.
  • GE HealthCare is not selling any shares of common stock and will not receive any proceeds from the sale of the GEHC Shares in the Offering or from the debt-for-equity exchange (as described below).
  • Prior to the closing of the Offering, General Electric Company (“GE”) is expected to exchange the GEHC Shares for indebtedness of GE held by Morgan Stanley Bank, N.A.

Pangaea Logistics Solutions Ltd. Announces Renewal of Shelf Registration Statement

Retrieved on: 
Friday, March 15, 2024
Form, Prospectus, Form S-3, Sale, Pangaea, Security (finance)

NEWPORT, R.I., March 15, 2024 /PRNewswire/ -- Pangaea Logistics Solutions Ltd. ("Pangaea" or the "Company") (Nasdaq: PANL), a global provider of comprehensive maritime logistics solutions, today announced the renewal, in the same aggregate amount, of its shelf registration statement on Form S-3, as filed with the Securities and Exchange Commission ("SEC"), replacing its recently expired shelf registration statement which expired on January 28, 2024.

Key Points: 
  • NEWPORT, R.I., March 15, 2024 /PRNewswire/ -- Pangaea Logistics Solutions Ltd. ("Pangaea" or the "Company") (Nasdaq: PANL), a global provider of comprehensive maritime logistics solutions, today announced the renewal, in the same aggregate amount, of its shelf registration statement on Form S-3, as filed with the Securities and Exchange Commission ("SEC"), replacing its recently expired shelf registration statement which expired on January 28, 2024.
  • The shelf registration statement has been filed with the SEC but has not yet been declared effective by the SEC.
  • This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.
  • Any offering of the securities covered under the shelf registration statement will be made solely by means of a prospectus and an accompanying prospectus supplement relating to that offering.

Landsea Homes Announces Closing of Secondary Common Stock Offering

Retrieved on: 
Friday, March 8, 2024
Prospectus, Suite, Telephone, Wedbush Securities, Sale, Exercise, Form, BofA Securities, Bank of America, Security (finance), Form S-3, Offering

DALLAS, March 08, 2024 (GLOBE NEWSWIRE) -- Landsea Homes Corporation (Nasdaq: LSEA) (“Landsea Homes” or the “Company”), a publicly traded residential homebuilder, announced today the closing of its previously announced underwritten secondary offering by its largest stockholder, Landsea Holdings Corporation (the “Selling Stockholder”), of 2,434,783 shares of the Company’s common stock, at a price of $11.60 per share (before underwriting discounts and commissions), and the full exercise by the underwriters of their option to purchase an additional 365,217 shares the Company’s common stock (the “Offering”).

Key Points: 
  • DALLAS, March 08, 2024 (GLOBE NEWSWIRE) -- Landsea Homes Corporation (Nasdaq: LSEA) (“Landsea Homes” or the “Company”), a publicly traded residential homebuilder, announced today the closing of its previously announced underwritten secondary offering by its largest stockholder, Landsea Holdings Corporation (the “Selling Stockholder”), of 2,434,783 shares of the Company’s common stock, at a price of $11.60 per share (before underwriting discounts and commissions), and the full exercise by the underwriters of their option to purchase an additional 365,217 shares the Company’s common stock (the “Offering”).
  • B. Riley Securities and BofA Securities acted as joint bookrunning managers in the Offering.
  • The Company did not offer any shares of its common stock in the Offering and did not receive any of the proceeds from the sale of the shares offered by the Selling Stockholder.
  • “The closing of the Offering marks a significant milestone for our company,” said Landsea Homes Chief Executive Officer John Ho.

INNOVATE Corp. Announces Commencement of Rights Offering

Retrieved on: 
Friday, March 8, 2024
Prospectus, Sale, Exercise, Form, Convertible, Panzer corps, Form S-3, Security (finance)

INNOVATE stockholders who exercise their respective full basic subscription rights will have over-subscription privileges giving such INNOVATE stockholders the option to subscribe for any shares of common stock that remain unsubscribed at the expiration of the rights offering.

Key Points: 
  • INNOVATE stockholders who exercise their respective full basic subscription rights will have over-subscription privileges giving such INNOVATE stockholders the option to subscribe for any shares of common stock that remain unsubscribed at the expiration of the rights offering.
  • Lancer Capital will not be permitted to exercise or transfer any subscription rights received by it, or to acquire other rights, in the rights offering, which rights are required to be held by Lancer Capital until the expiration thereof.
  • For any questions or further information about the rights offering, please call Okapi Partners LLC, the information agent for the rights offering, at (855) 208-8902 (toll-free).
  • Neither the Company nor its Board of Directors has, or will, make any recommendation to stockholders regarding the exercise or sale of rights in the rights offering.

Paycor Announces Pricing of Offering of Common Stock by Selling Stockholders

Retrieved on: 
Thursday, March 7, 2024
AIX, Apax Partners, Goldman Sachs, LP, Prospectus, Telephone, Sale, Form, HCM, Security (finance), Form S-3

The offering consists of 5,651,106 shares offered by Pride Feeder, LP and 2,348,894 shares offered by AIX Pride Syndication L.P., respectively.

Key Points: 
  • The offering consists of 5,651,106 shares offered by Pride Feeder, LP and 2,348,894 shares offered by AIX Pride Syndication L.P., respectively.
  • Each of the selling stockholders are controlled by investment funds advised by Apax Partners LLP.
  • Pride Aggregator, LP will distribute 11,038,476 shares of Paycor’s common stock to its limited partners prior to the closing of the offering, including the selling stockholders.
  • These forward-looking statements reflect Paycor’s current intentions, expectations or beliefs regarding the common stock offering.

Paycor Announces Offering of Common Stock by Selling Stockholders

Retrieved on: 
Wednesday, March 6, 2024
AIX, Apax Partners, Goldman Sachs, LP, Prospectus, Telephone, Sale, Form, HCM, Security (finance), Form S-3

Each of the selling stockholders are controlled by investment funds advised by Apax Partners LLP.

Key Points: 
  • Each of the selling stockholders are controlled by investment funds advised by Apax Partners LLP.
  • Pride Aggregator, LP will distribute 11,038,476 shares of Paycor’s common stock to its limited partners prior to the closing of the proposed offering, including the selling stockholders.
  • The proposed offering of common stock will be made pursuant to the Company’s shelf registration statement on Form S-3 filed with the Securities and Exchange Commission (“SEC”) and declared effective.
  • These forward-looking statements reflect Paycor’s current intentions, expectations or beliefs regarding the proposed common stock offering.